101. PARKINSON'S DISEASE Parkinson s disease is caused by progressive deterioration of the nerve cells Can I know the incidence for PARKINSON S disease in india can any one help http://www.medindia.net/patients/patientinfo/parkinsonsdisease.asp

Bookmark This Page About Us Contact Us Feedback ... Log In September 24, 2005 Home Directories Professionals Consumer Health ... My Health Record Search Web Medindia.com Medindia Advanced Search P owered By G o o g l e Medindia Disease/Health Information PARKINSON'S DISEASE PARKINSON'S DISEASE Disease info Related Topics Medical Acronyms Amazing Body Facts Phobias Medical Syndromes ... Teeth Chart Interactives (Flash) Brain Depression Eye Donation Brain Death Angioplasty ... Glossary General Info about Parkinson's Disease It was first described by James Parkinson in England in 1817. The disease most often develops after age 50. It affects both men and women and is one of the most common neurologic disorders of the elderly. The disease itself causes degeneration of nerve fibres. The brain consists of cells called 'Neurons' and their fibres called 'Nerves'. Nerves are like cables and in some conditions, thinning of these cables occur; this is known as degeneration . The patient can [rarely] form any recollection of the precise period of its commencement. The first symptoms perceived are, a slight sense of weakness, with a proneness to trembling in some particular part; sometimes in the head, but most commonly in one of the hands and arms . The propensity to lean forward becomes invincible . As the debility increases and the influence of the will over the muscles fades away, the tremulous agitation becomes more vehement.

102. HON - News : Drug Breakthroughs Offer Hope For Parkinson's Patients Parkinson s disease involves the steady loss of brain cells that produce An estimated 1 million to 1.5 million Americans have Parkinson s disease, http://www.hon.ch/News/HSN/519900.html

What is it? Speech: On / Off HONcode sites All Web sites HONselect News ... X Y Z Browse archive: S A J J ... J Posting date: 04-JUL-2004 Other news for: Parkinson Disease Resources from HONselect Drug Breakthroughs Offer Hope for Parkinson's Patients Yet a cure remains elusive, researchers acknowledge By Barry Hoffman HealthDay Reporter SUNDAY, July 4 (HealthDayNews) A drug approved in April by the U.S. Food and Drug Administration brings yet another source of relief to those who suffer from the debilitating malady known as Parkinson's disease. The FDA granted approval to the drug Apokyn (apomorphine), made by Bertek Pharmaceuticals, which treats periods of immobility that affect some people with Parkinson's disease. During these "off-period" episodes, medically known as "hypomobility," some people on standard anti-Parkinson's drugs can lose the ability to speak, rise from a chair, or walk. These episodes tend to occur as the drugs begin to wear off between dosing cycles. The debilitating condition affects about 10 percent of the patients who take standard Parkinson's therapies. Apokyn must be taken with another medication to counter its nasty side effects, which include severe nausea and vomiting, the FDA said. The drug's labeling also includes specific warnings about low blood pressure, fainting, hallucinations and excessive sleepiness.

103. Patient Resources : Parkinson's Disease Parkinson s disease Drugs May Cause Pathological Gambling Azilect (Rasagiline) for Parkinson s disease is Now Available in the United Kingdom; http://www.docguide.com/news/content.nsf/PatientResAllCateg/Parkinson's Disease?

104. Neurology (2) Parkinson's Disease: Treatment In this second article on Parkinson s disease, we consider treatment of the The treatment of Parkinson s disease (PD) was revolutionised by the http://www.pharmj.com/Editorial/20000325/education/parkinsons2.html

The Pharmaceutical Journal Vol 264 No 7089 p476-479 March 25, 2000 Continuing education Neurology (2) Parkinson's disease: treatment By David Burn, FRCP, MD In this second article on Parkinson's disease, we consider treatment of the condition and look at what might be available to patients in the future. The first article was an overview of the condition ( PJ , February 26, pp333-337 Other articles in the neurology series include: Parkinson's disease: an overview Multiple sclerosis: the disease and its treatment Alzheimer's disease The treatment of Parkinson's disease (PD) was revolutionised by the introduction of levodopa in 1967. In the relatively short period of time that has followed, the limitations of levodopa have been recognised and an increasing number of alternative drugs have been developed in an effort to circumvent these shortcomings. Furthermore, the "therapeutic wheel" has almost turned a full circle, as neurosurgical approaches, which were largely abandoned after levodopa treatment became available, are being re-evaluated for their potential role in disease management. This review of the treatment of PD primarily considers currently available drugs. These are symptomatic therapies, since no agent has yet been shown beyond reasonable doubt to have disease modifying, or "neuroprotectective", properties. Finally, neurosurgical treatments and a number of potential future therapies for PD will be briefly reviewed.

105. Parkinson's Disease - Common Symptoms And Treatment Information BUPA health factsheet the cause of Parkinson s disease is unknown although we do understand that it results from the loss of dopamine in the brain. http://hcd2.bupa.co.uk/fact_sheets/html/Parkinsons_disease.html

search home services health information ... BUPA Products and services Health insurance Financial protection Hospitals Cosmetic surgery ... International cover Visitor interest areas Individuals Business Intermediaries Health professionals ... BUPA members Facilities finder Find local health and fitness facilities World of BUPA BUPA services around the world at bupa.com health information health factsheets Print-friendly version ... Need help with PDF files? Parkinson’s disease Parkinson’s disease is a condition affecting the nervous system. It causes muscle tremor, stiffness and slowness of movement that becomes progressively worse over time. The condition was first described by Dr James Parkinson in 1817. It affects approximately one in 100 people over 65 years old, and one in 10 people over 80. The symptoms of Parkinson’s disease often begin around the age of 55. What causes Parkinson’s disease? In Parkinson’s disease, production of a substance called dopamine in the brain is reduced. Dopamine is a neurotransmitter involved in passing messages within the brain and from the brain to the muscles. The part of the brain affected is called the substantia nigra, which co-ordinates muscle movement. No one knows exactly what causes Parkinson's disease, but studies with identical twins suggest that genetic factors play a part. Also, some patients with generalised brain disease get Parkinson-like symptoms, which suggests that earlier damage to the brain might have a role in causing the disease. Parkinson’s disease is not contagious.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 6     101-105 of 105    Back | 1  | 2  | 3  | 4  | 5  | 6